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Copyright © 2005 by The American Asso-
ciation for Thoracic Surgerydoi:10.1016/j.jtcvs.2004.08.047Objective: In November 1998, our center began offering alcohol ablation as an
alternative to surgical myectomy for patients with hypertrophic obstructive cardio-
myopathy. Patients with concomitant lesions were referred for surgical intervention,
and the others were offered either treatment option. We sought to review the early
outcomes for both protocols.
Methods: One hundred fifty patients had intervention for hypertrophic obstructive
cardiomyopathy to June 30, 2003. Sixty patients elected to have alcohol ablation,
and 5 crossed over to surgical intervention. A total of 95 patients had a myectomy.
Patients having an isolated myectomy (n  48) are compared with those who had
an ablation. Hospital records were reviewed, and follow-up contact (mean, 2.2
years) with the patient or referring cardiologist and recent echocardiographic reports
were obtained. Differences in clinical and hemodynamic outcomes between
achieved treatment groups were compared after adjustment for differing baseline
patient characteristics, including use of a propensity score, to adjust for the non-
randomization.
Results: The patients undergoing alcohol ablation (n  60) were older (58 vs 48
years) and had fewer associated lesions (1 vs 39 patients), lower pressure gradients
(67 vs 73 mm Hg), and similar symptomatic status and degrees of mitral regurgi-
tation compared with those in the myectomy group. Alcohol ablation was aban-
doned in 6 patients, 5 of whom underwent myectomy. Among the completed alcohol
ablations, there were 5 late deaths, and 1 other patient was referred for myectomy.
One late death occurred after myectomy. At latest follow-up, 3-year survival is 97%,
and 92% of the patients are in New York Heart Association class II or I. Adjusted
comparisons showed significantly lower postintervention left ventricular outflow
gradients at rest in the myectomy group (5 vs 15 mm Hg), with provocation (14 vs
42 mm Hg), mitral systolic anterior motion (67% vs 29%), and New York Heart
Association class. No significant difference was present in postintervention septal
thickness or freedom from postintervention pacing, although in time-related anal-
ysis, the 3-year freedom from pacing is 88% versus 59% (P  .02), favoring
myectomy.
Conclusion: Either alcohol ablation or myectomy offers substantial clinical
improvement for patients with hypertrophic obstructive cardiomyopathy. He-
modynamic resolution of the obstruction and its sequelae is more complete with
myectomy. Residual lesions after alcohol ablation might affect longer-term
outcomes.
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DHypertrophic obstructive cardiomyopathyis an inherited disorder with variable ex-pressivity, resulting in asymmetric septalhypertrophy and left ventricular outflowtract obstruction. Symptoms are similar tothose of aortic stenosis. Goals of treat-
ment include symptomatic control, resolution of hemody-
namic abnormalities and their sequelae, reduction of sudden
cardiac death risk, and screening of family members. Left
ventricular outflow tract obstruction at rest is a predictor of
severe symptoms, heart failure, and death.1 The majority of
patients are managed medically, predominantly with
-blockers. Surgical treatment has been limited to patients
with refractory symptoms and high resting gradients. Re-
sults of surgical intervention are well documented, with
95% of patients being asymptomatic with accompanying
dramatic reduction in outflow tract gradient.2-7 Alcohol
ablation is a newer percutaneous technique that was first
used at our institution in November 1998.8-10 It is designed
to ablate hypertrophied cardiac septal muscle through local-
ized infarction, but its efficacy compared with that of sur-
gical myectomy is uncertain.11
In this communication we compare these 2 treatment
modalities using propensity adjustment to compare their
effects on symptoms and hemodynamics.
Methods
At the Toronto General Hospital between November 1998 and
December 2003, 150 symptomatic adults with hypertrophic ob-
structive cardiomyopathy underwent intervention for left ventric-
ular outflow tract obstruction. During this period, 60 patients were
referred for alcohol ablation, and 90 patients were referred for
surgical myectomy. Operations were performed as described pre-
viously.2 Alcohol ablation was performed with echocardiographic
contrast guidance, as previously described.8-10
Myectomy was performed in 90 patients referred directly to
surgical intervention and in 5 others after attempted ablation.
Among this group of 95 patients, 48 patients had an isolated septal
myectomy, and 47 patients had a myectomy and a concomitant
procedure. The 54 patients who received alcohol ablation and the
48 surgical patients who had an isolated myectomy were compared
with respect to symptom status, echocardiographic parameters of
left ventricular outflow tract obstruction and mitral regurgitation,
need for additional procedures, and survival.
Data Analysis
Data are described as frequencies, medians with ranges, and means
with SDs. Where there are missing data, the number of nonmissing
values is given.
Initial differences in baseline characteristics between achieved
treatment groups were sought in bivariable analysis by using 2
tests, Fisher exact tests, Student t tests, and Kruskal-Wallis anal-
ysis of variance. Multiple logistic regression analysis was used to
determine independent baseline variables predictive of member-
ship in the ablation group. Multivariable analysis was used after
imputation of missing values with the mean value for the com-
352 The Journal of Thoracic and Cardiovascular Surgery ● Febrbined groups to adjust for any differences at baseline between the
groups being compared. Multiple logistic regression incorporating
all significant baseline variables was used to derive a propensity
score or the predicted probability that an individual patient be-
longed to the ablation group. Comparisons between groups regard-
ing outcome variables was then performed unadjusted, adjusted for
significant baseline variables, and adjusted for significant baseline
variables and propensity score in multivariable regression analysis.
All statistical analyses were performed with SAS statistical soft-
ware (Version 8; SAS Institute, Inc, Cary, NC).
Results
Study Subjects
The study included 155 intended procedures in 150 patients,
including 60 intended alcohol ablations and 90 intended
surgical myectomies. Of the 60 intended ablations, 54 were
completed, including one patient who subsequently went on
to have a surgical myectomy because of ongoing symptoms
and an important residual gradient. Of the 6 patients who
did not have an intended ablation, 5 subsequently had sur-
gical myectomy (however, one patient’s successful opera-
tion was outside of the study period and was not included),
and one patient had no further procedures except pacemaker
placement. All 90 intended surgical myectomies were per-
formed. However, added to the surgical group are 4 of the
patients who were intended to have ablation but did not, and
one patient who had ablation followed by later myectomy,
for a total of 95 myectomies. Of the 95 myectomies, 48
were performed as isolated procedures and serve as the
group for comparison with the 54 completed ablation
procedures.
Comparison of Isolated Surgical Myectomy (n  48)
Versus Completed Alcohol Ablation (n  54)
The preprocedure characteristics of each group are shown in
Table 1. In univariate comparisons the patients undergoing
alcohol ablation were significantly older, had higher resting
systolic blood pressure, were less likely to have angina or
palpitations or presyncope-syncope, had better New York
Heart Association (NYHA) class, were more likely to have
coronary artery disease, and had decreased thickness of the
ventricular septum and posterior wall relative to the patients
undergoing isolated surgical myectomy. These same fac-
tors, except coronary artery disease and septal thickness,
independently differentiated the 2 groups in stepwise mul-
tiple logistic regression analysis, with a c statistic of 0.908.
These factors, together with missing value flags, were en-
tered in multiple logistic regression analysis to create the
propensity score or the probability that a given patient was
in the alcohol ablation group.
Duration of Postprocedure Hospitalization
There were no deaths during the postprocedure hospitaliza-
tion. Median duration was 8 days (range, 4-37 days) for the
alcohol ablation group versus 7 days (range, 3-19 days) for
uary 2005
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Dthe isolated myectomy group (P  .46). None of the base-
line variables were significantly associated with duration of
TABLE 1. Comparison of baseline characteristics betwee
undergoing surgical myectomy with no concomitant proce
Alc
Male/female sex
Mean age at procedure (y)
Mean weight at procedure (kg)
Mean body surface area (m2) 1
Mean resting systolic blood pressure (mm Hg) 1
Mean resting diastolic blood pressure (mm Hg)
Symptoms
Dyspnea 40
Angina 22
Palpitations 2
Presyncope-syncope 4/51 (8%) 18
Medications at procedure
-blocker 35
Disopyramide 40
Aspirin 2
Preprocedure coronary artery disease 9
Muscle bridge of LAD
Preprocedure heart rhythm
Normal sinus rhythm
Paced
Atrial fibrillation
Preprocedure echocardiogram
Aortic regurgitation
None
Trivial
Mild
Mitral regurgitation
Trivial
Mild
Mild to moderate
Moderate
Moderate to severe
Severe
Systolic anterior motion of MV
None
Mild
Moderate
Moderate to severe
Severe
LVOT gradient at rest (mm Hg)
Septal thickness (mm)
LV posterior wall thickness
LV mass index (g/m2) 1
Left atrial size (mm)
LV end-diastolic dimension (mm)
LV end-systolic dimension (mm)
LAD, Left anterior descending coronary artery; MV, mitral valve; LVOT, lehospitalization. When the groups were compared after pro-
The Journal of Thoracipensity adjustment, the alcohol ablation group had signifi-
cantly longer postprocedure hospitalizations (adjusted esti-
ose undergoing achieved alcohol ablation versus those
s
ablation
54)
Surgical myectomy
(n  48) P value
:28 30:18 .15
15 46  17 .001
18 85  18 .49
0.23 1.98 0.27 .13
23 (52) 118 16 (45) .02
12 (52) 72 11 (45) .31
8%) 42/48 (88%) .24
3%) 31/48 (65%) .04
%) 15/48 (31%) .001
8%) .001
1%) 30/44 (68%) .74
2%) 35/44 (80%) .80
%) 0/44 (0%) .50
8%) 0/46 (0%) .003
%) 1 (2%) 1.00
53 n  45
1%) 42 (93%)
%) 1 (2%)
%) 2 (5%)
53 n  40
5%) 25 (63%)
0%) 13 (35%)
5%) 2 (5%) .22
%) 4 (8%)
6%) 8 (17%)
%) 10 (21%)
3%) 19 (40%)
4%) 3 (6%)
%) 4 (8%) .34
50 n  47
%) 1 (2%)
2%) 11 (23%)
0%) 19 (40%)
0 1 (2%)
8%) 15 (32%) .21
36 (53) 64 27 (47) .13
5 (50) 25 6 (46) .04
3 (48) 12 3 (43) .05
40 (45) 165 52 (38) .45
6 (48) 47 8 (47) .73
5 (48) 43 6 (44) .85
4 (48) 23 7 (42) .30
tricular outflow tract; LV, left ventricular.n th
dure
ohol
(n 
26
59
82
.90
29
75
/51 (7
/51 (4
/51 (4
/48 (3
/49 (7
/49 (8
/49 (4
/49 (1
2 (4
n 
48 (9
5 (9
0 (0
n 
29 (5
16 (3
8 (1
1 (2
14 (2
5 (9
18 (3
13 (2
3 (6
n 
0 (0
11 (2
15 (3
24 (4
74
22
11
57
47
43
24mate, 4.1 days longer; P  .02).
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DMortality
During follow-up, there were 5 deaths in the alcohol abla-
tion group (2 sudden, 1 congestive heart failure, 1 malig-
nancy, and 1 after liver transplantation). No deaths occurred
in the isolated myectomy group. Kaplan-Meier estimates for
time-related survival in the alcohol ablation group were
94% at 1 year and 90% at 4 years, with one death occurring
at 4.6 years after the procedure. This was significantly
different from the isolated myectomy group (P  .02,
Figure 1). Given the small number of events, no baseline
variable was significantly associated with time-related sur-
vival, and no adjusted analysis was performed.
Pacemaker Placement
Before the procedure, 6 patients in each group had a per-
manent pacemaker placement. Excluding these 12 patients,
time-related survival free of pacemaker placement was de-
termined for each group (Figure 2) and was significantly
greater in the isolated myectomy group in an unadjusted
comparison (hazard ratio, 2.65; P  .05). The only baseline
variable significantly associated with an increased risk of
time-related pacemaker placement was the presence of cor-
onary artery disease (hazard ratio, 2.98; P  .05). After
adjusting for this variable, the difference in risk of pace-
maker placement was no longer statistically significant be-
tween the groups (hazard ratio, 2.34; P  .10), including
after additional adjustment with propensity score (hazard
ratio, 2.98; P  .14).
NYHA Class at Latest Follow-up
NYHA functional class data were available at latest follow-up
for 47 patients in the alcohol ablation group and 42 patients in
the isolated myectomy group at a mean interval of 2.3  1.3
years after the procedure. For the alcohol ablation group, 19
were in class I, 24 were in class II, and 4 were in class III, and
for the isolated myectomy group, 34 were in class I, 6 were in
class II, and 2 were in class III (P  .001). In ordinal logistic
regression the baseline variables significantly associated with
Figure 1. Survival after intervention with alcohol ablation or after
isolated myectomy is plotted by using Kaplan-Meier analysis.worse functional class included older age at the time of the
354 The Journal of Thoracic and Cardiovascular Surgery ● Febrprocedure (odds ratio, 1.04; P  .02), female sex (odds ratio,
3.30; P  .02), and larger preprocedure size of the left atrium
(odds ratio, 1.09; P  .01). The patients undergoing alcohol
ablation had significantly worse functional class after adjust-
ment for these variables (odds ratio, 5.40; P .004), and after
additional adjustment with propensity score (odds ratio, 5.43;
P  .05).
Echocardiographic Assessment at Latest Follow-up
Echocardiographic assessments had been performed in all
of the patients undergoing alcohol ablation and in 46 of the
patients undergoing isolated myectomy at a mean interval of
2.0  1.3 years after their procedures (Table 2). Postinter-
vention resting left ventricular outflow gradients were sig-
nificantly higher in patients who underwent alcohol abla-
tion. In general linear regression modeling, a higher
gradient was significantly associated with the baseline vari-
ables of older age at procedure and better NYHA functional
class. After adjusting for these 2 baseline variables, resting
gradient remained significantly higher in the alcohol abla-
tion group (adjusted difference, 14 mm Hg; P  .001), a
difference that persisted after additionally adjusting with
propensity score (P  .002). Provoked left ventricular out-
flow gradients were also significantly higher in patients who
underwent alcohol ablation. In general linear regression
modeling, a higher provoked gradient was significantly as-
sociated with the baseline variables absence of syncope and
better NYHA functional class. After adjustment, provoked
gradient remained significantly higher in the alcohol abla-
tion group (adjusted difference, 25 mm Hg; P  .001) and
remained so after additional adjustment with propensity
score (P  .004).
The presence of systolic anterior motion of the mitral
valve (SAM) after intervention was significantly higher in
Figure 2. Survival free of a permanent pacemaker implant is
shown by using Kaplan-Meier analysis for the ablation and iso-
lated myectomy (M-ISOL) groups. For this analysis, the 6 patients
in each group who had a pacemaker before intervention are
excluded.the alcohol ablation group. In multiple logistic regression
uary 2005
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ables of greater left ventricular end-diastolic dimension and
better NYHA functional class. After adjusting for these 2
baseline variables, SAM remained more likely in the alco-
hol ablation group (odds ratio, 4.02; P  .006), even after
additional adjustment with propensity score (P  .01). The
presence of moderate or greater grade of mitral valve re-
gurgitation was not significantly different between groups,
even after adjusting for the significant baseline variables of
presence of preprocedure arrhythmia and greater left ven-
tricular end-systolic dimension (P  .96) and additionally
for propensity score (P  .65). Similarly, the postprocedure
prevalence and severity, usually trivial, of aortic insuffi-
ciency was not significantly different after ablation (37%)
versus myectomy (41%).
An optimal composite outcome at follow-up was defined
as survival, NYHA functional class I, no postprocedure
pacemaker placement, and a follow-up resting left ventric-
ular outflow gradient of less than 20 mm Hg. This was noted
in 12 (22%) patients in the alcohol ablation group and 35
(73%) patients in the isolated myectomy group (P  .001).
Discussion
There are no randomized prospective studies to compare the
efficacy of alcohol ablation versus surgical myectomy. Only
3 publications compare the outcomes of both.11-13 Qin and
colleagues,12 comparing 25 patients undergoing alcohol ab-
lation with 26 patients undergoing myectomy, found myec-
tomy to be more effective in reducing left ventricular out-
flow tract gradient immediately after the procedure and at 3
months’ follow-up. Both procedures had similar effects on
NYHA classification. The second study of Qin and col-
leagues13 compared the conduction abnormalities after in-
tervention, demonstrating that ablation commonly results in
right bundle branch block (62%), whereas myectomy causes
left bundle branch block (93% of their patients). One im-
plication of their observation is that patients with preproce-
dure conduction block will almost certainly need permanent
TABLE 2. Comparison of follow-up echocardiographic va
versus surgical myectomy with no concomitant procedure
Mean interval to echocardiography (y)
Resting LV outflow gradient (mm Hg)
Provoked LV outflow gradient (mm Hg)
Presence of systolic anterior motion of the mitral valve
Presence of moderate or more severe mitral valve regurgitation
LV, Left ventricular.
*Unadjusted.
†Adjusted for significant baseline variables.
‡Adjusted for significant baseline variables and propensity score.cardiac pacing if they have right bundle branch block and
The Journal of Thoraciare undergoing an operation or left bundle branch block and
intending to have ablation. The one patient in our series who
crossed over to myectomy after ablation did require pacing.
Although pacing is less prevalent after myectomy in this
series, the difference is not significant after adjusting for the
prevalence of coronary artery disease. The absence of cor-
onary disease in our patients undergoing isolated myectomy
is due to the fact that those patients requiring coronary
artery bypass were excluded from the isolated myectomy
group. The prevalence of pacing is not different between the
isolated myectomy and myectomy with concomitant oper-
ation groups (12.5% vs 12.7%), but the risk of pacing is
higher after ablation (19%; Figure 2).
Nagueh and associates14 compared 41 patients undergo-
ing ablation treated at Baylor with 41 patients undergoing
myectomy treated at the Mayo Clinic. In their series the
hemodynamic and functional results at 1 year after the
procedure were similar in both groups. In contrast, our
patients undergoing myectomy had lower pressure gradients
at rest and with provocation, better functional class, and less
SAM (although similar mitral regurgitation) compared with
the patients undergoing ablation. Naqueh and associates had
additional information regarding exercise duration and vol-
ume of oxygen use peak and maximum, and these were also
equivalent in both groups. Complications of intervention in
Nagueh and associate’s series include complete atrioven-
tricular block, which was more common after ablation (22%
vs 2%), and aortic insufficiency, which was more common
after myectomy. Aortic insufficiency, mild or more severe,
was not significantly different in our series.
Univariate analysis of our study patient demographics
revealed that patients undergoing alcohol ablation were
older, with more hypertension, better NYHA class, more
coexistent coronary artery disease, and lesser degrees of
septal hypertrophy compared with surgical patients, who
had a higher incidence of angina, palpitations, and presyncope-
syncope with a thicker interventricular septum. Statistical
attempts to propensity match patients from both groups
es between those undergoing achieved alcohol ablation
ohol ablation
(n  54)
Surgical myectomy
(n  46) P value* P value† P value‡
.8  1.1 2.3  1.5 .07
15 (0, 96) 5 (0, 17) .001 .001 .002
125), n 50 14 (0, 42), n 27 .001 .001 .004
32/48 (67%) 12/41 (29%) .001 .006 .01
8/53 (15%) 6/45 (13%) .84 .96 .65riabl
s
Alc
1
42 (0,were unsuccessful, demonstrating that the 2 groups are
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Dinherently different. Propensity adjustment scores corrected
these differences between the alcohol ablation and isolated
myectomy groups. After propensity adjustment, patients
treated with alcohol ablation had significantly higher post-
procedural resting (P  .002) and provokable outflow tract
gradients (P  .004), more SAM (P  .01), and worse
NYHA classification at most recent follow-up (P  .05).
The alcohol ablation group also had longer postprocedural
length of stay (P  .04), perhaps because of a learning
curve related to this new procedure and delayed discharge
while confirming the absence of atrioventricular block.
Mortality is statistically higher after alcohol ablation
compared with that after isolated myectomy (or myectomy
with concomitant procedures). All 3 cardiac-related deaths
occurred in the ablation group. However, the number of
patients in our study is small, with few deaths, and therefore
this difference in survival needs to be confirmed. The com-
bination of higher residual outflow tract gradients at rest and
with provocation and the subendocardial scaring in patients
receiving alcohol ablation might, however, increase the
likelihood of postprocedural arrhythmia.14 Others have re-
ported ventricular tachycardia complicating ablation.13
Significantly more patients achieved the defined optimal
outcome after myectomy compared with that after alcohol
ablation (73% vs 22%, P  .001).
Results from this study might not be generally applica-
ble; surgical myectomy is an established procedure at our
institution, whereas the indications, technique, and care of
patients undergoing alcohol ablation are new and evolving.
We are comparing the performance of 2 procedures with
differing patient referral patterns without randomization,
and follow-up is relatively short, with small numbers of
patients. The long-term effects of higher provokable gradi-
ents and scarring in the hypertrophic ventricle of patients
undergoing ablation are unknown and will require ongoing
careful patient follow-up.15
We have attempted to adjust the effect of differences in
baseline patient characteristics using propensity scores. Our
data suggest that the outcomes after isolated surgical my-
ectomy are significantly better than those after alcohol ab-
lation. There are sufficient data to justify a prospective
multicenter trial of the 2 modalities of treatment to deter-
mine the optimal management of patients with the obstruc-
tive form of hypertrophic cardiomyopathy.
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Discussion
Dr Rene Pretre (Zurich, Switzerland). Dr Williams, you are to be
congratulated for having convincingly shed light on the 2 thera-
peutic options that exist now for the treatment of hypertrophic
cardiomyopathy, namely alcohol ablation and surgical myectomy.
You have further performed a sound statistical analysis to compare
comparable subgroups using, in the absence of randomization,
adjustment for baseline patient characteristics and propensity score
in multivariable regression analysis.
Overall, your results were good in both groups, although sur-
gical intervention achieved better outcome, especially regarding
hard facts, such as improvement of clinical status, need for sub-
sequent pacemaker implantation, and reduction of the outflow tract
obstruction and its inherent consequences. Follow-up is, however,
relatively short. I have 3 questions for you.
The first question relates to the incidence of arrhythmia late
after the procedure both at the atrial and the ventricular level. What
was the incidence of atrial fibrillation late after the procedure, a
complication that occurred steadily in our experience, up to 25%
after 7 years, and also, have you performed Holter monitoring to
detect dangerous ventricular arrhythmia late after surgical inter-
vention that could justify the implantation of a defibrillator, for
instance?
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DDr Williams. The question of arrhythmias in hypertrophic
cardiomyopathy is an excellent one. Off the top of my head, I
cannot recall what percentage had atrial fibrillation. There were 2
patients who underwent a maze procedure for chronic atrial fibril-
lation, but they are not in the comparative group because they had
concomitant procedures. Otherwise, the prevalence of atrial fibril-
lation was not extensive.
What is of concern, of course, is ventricular tachycardia fibril-
lation and sudden death, and it is worrisome that there were 2
sudden unexpected deaths in the ablation group. We have concerns
that the scar caused by the alcohol ablation might be arrhythmo-
genic over the longer period of time, particularly early after abla-
tion, when these patients will often have a residual gradient,
because it takes some time for that gradient to reach a low level.
Dr Prêtre. After having established a technique for alcohol abla-
tion at your institution, have you observed a decrease in the proportion
of patients sent to surgical intervention? This trend has been seen in
some hospitals because of the pressure of the referring cardiologist,
who wants a less-invasive, although less-efficient, operation.
Dr Williams. It was interesting and somewhat surprising to me
that the percentage of patients referred for surgical intervention
over this 5-year period did not change; it was around 61% referred
for intervention. Half of the surgical referrals were because of
concomitant diseases that needed to be treated. The other half were
patients who could have gone either to ablation or surgical inter-
vention. As a policy, both the interventionalist and the surgeons
interviewed these patients, and then we allowed the patients to
decide. Therefore we expected these 2 groups would be equivalent,
but when we tried to propensity match them, it was clear there
were important differences between the 2 groups, and therefore we
were unable to use propensity matching and had to rely on the
propensity score.
Dr Prêtre. Maybe a practical question. You reported residual
left ventricular outflow tract obstruction after provocation of 42
mm Hg after alcohol ablation and only 14 mm Hg after surgical
myectomy. If you have a young and physically active patient, what
would be your recommendation? Would you do alcohol ablation
and leave some kind of residual obstruction where the patient
would reach this critical gradient and maintain hypertrophy of his
left ventricle and remain at risk for sudden death, or would you
suggest surgical myectomy on this individual?
Dr Williams. You are asking a surgeon whether he would
recommend surgical intervention?
Dr Prêtre. You were soft in your conclusions stating that both
therapies achieved acceptable results. Because you are in the
process of decision making with your colleagues, I expect you
would recommend surgical intervention in those active patients.
Dr Williams. Well, I think your question is an important one,
and the reason for doing this analysis and presenting the informa-
tion is that I think there is serious concern that the patients have
better access to the catheterization laboratory than they do to the
operating room. The conclusion that I make from this study is that it
justifies doing a multicenter trial to demonstrate the benefits of one or
the other treatment. There might be situations in which alcohol abla-
tion is a better choice, but if you wanted to be certain that you were
relieving the pressure gradient both at rest and at exercise and prob-
ably have a better long-term survival, then I think the data suggest
very clearly that surgical myectomy is the better option.
The Journal of ThoraciDr Richard J. Shemin (Boston, Mass). This was a nice study
and very important. I am interested in 2 questions. In patients who
are referred for alcohol ablation, do you know how often they find
unfavorable septal anatomy, such as very small septals that cannot
be cannulated or a single large septal perforator where a massive
septal infarct might ensue? In these cases alcohol ablation would
be aborted.
Dr Williams. To back up a little bit, I think that some of the
patients were not referred for ablation if they had particularly thick
septa. I think they were worried about infarcting too large an area,
and these patients can get sick after ablation.
In terms of the ones who did go to the catheterization labora-
tory and were not ablated, of which there were 6, 5 were because
the anatomy was unfavorable and they could not either get into the
right area or be certain they were infarcting the correct area. One
of the 6 patients had an acute dissection of the coronary arteries
and went to the operating room on an emergency basis, requiring
a triple bypass and myectomy in spite of going into the catheter-
ization laboratory with normal coronary arteries. Therefore this
procedure did have some risk involved.
Dr Shemin. My second question relates to hospital resource
use. Do you know whether they monitor these patients after the
control infarct in the cardiac care unit for a few days, and what was
the average length of stay of the patient receiving alcohol ablation?
Dr Williams. Interestingly, the length of stay in the patients
undergoing alcohol ablation was longer than in the surgical pa-
tients, and when you adjust it by propensity score, it was longer by
4 days. Therefore from an in-hospital consumption standpoint, the
surgical myectomy is more effective. Part of the long stay was
their caution in undertaking a new procedure and making sure the
physicians were not going to miss something when the patients
went home.
Dr Alain Carpentier (Paris, France). I have 2 brief questions.
You mentioned 5 cases of valve repair. Could you tell us what type
of valve repair you were able to do?
Dr Williams. You are speaking of mitral valve repair?
Dr Carpentier. Yes.
Dr Williams. I think that the valve in hypertrophic obstructive
cardiomyopathy almost always does not need to be repaired be-
cause it is secondary to the obstruction. When we relieve the
obstruction, the mitral valve resumes its normal flow pattern and
works quite well, and almost none of these patients had important
regurgitation afterward. However, there is a small subset of pa-
tients with hypertrophic cardiomyopathy who concomitantly have
mitral valve disease. These valves need to be repaired or, rarely,
replaced by means of whatever technique is causing the regurgi-
tation. It can be any of the various mitral lesions leading to
regurgitation.
Dr Carpentier. There is another criterion to assess the quality
of the results, which is whether you can diminish or even suppress
the medical treatment. Could you elaborate on that and tell us
whether you were able to discontinue medical treatment after
myectomy and in which proportion?
Dr Williams. I do not have comparative data, and you have a
very good point. I can tell you that most of the patients undergoing
surgical myectomy are not receiving medication unless it is to
suppress an arrhythmia.
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DDr Paul Kurlansky (Miami Beach, Fla). It is my understand-
ing that the risk of sudden cardiac death in hypertrophic cardio-
myopathy is not well correlated with symptomatic outflow ob-
struction, but what I was wondering is the following: Do you have
any evidence from your work or that of others that surgical
myectomy and relief of outflow tract obstruction has any effect on
the long-term risk of sudden cardiac death in the patients with
hypertrophic cardiomyopathy?
Dr Williams. Your question refers to the long-term survival358 The Journal of Thoracic and Cardiovascular Surgery ● Febrreview of this in The New England Journal of Medicine about a
year ago showing that long-term survival is related to the septal
thickness, and we undertook a study of all of our patients under-
going myectomy to see whether outcomes were affected by
myectomy.
Mortality after myectomy is very low and probably better than
the natural history. The patients with thicker septa did not do better
or worse in the long term. In other words, the benefit of surgical
intervention seemed to be about the same, irrespective of whetherwith and without myectomy. I think Dr Maron had a very nice the patient has a thin septum or a thick septum.uary 2005
